Bitte beachten Sie: Im Zeitraum vom 21.12.2024 bis zum 07.01.2025 werden auf hohPublica keine Anfragen oder Publikationen durch das KIM bearbeitet. Please note: KIM will not process any requests or publications on hohPublica between December 21, 2024 and January 7, 2025.
 

NOD1 cooperates with HAX‐1 to promote cell migration in a RIPK2‐ and NF‐ĸB‐independent manner

dc.contributor.authorHezinger, Lucy
dc.contributor.authorBauer, Sarah
dc.contributor.authorEllwanger, Kornelia
dc.contributor.authorPiotrowsky, Alban
dc.contributor.authorBiber, Felix
dc.contributor.authorVenturelli, Sascha
dc.contributor.authorKufer, Thomas A.
dc.date.accessioned2024-07-05T13:49:58Z
dc.date.available2024-07-05T13:49:58Z
dc.date.issued2023
dc.date.updated2024-06-27T03:44:49Z
dc.description.abstractThe human Nod-like receptor protein NOD1 is a well-described pattern-recognition receptor (PRR) with diverse functions. NOD1 associates with F-actin and its protein levels are upregulated in metastatic cancer cells. A hallmark of cancer cells is their ability to migrate, which involves actin remodelling. Using chemotaxis and wound healing assays, we show that NOD1 expression correlated with the migration rate and chemotactic index in the cervical carcinoma cell line HeLa. The effect of NOD1 in cell migration was independent of the downstream kinase RIPK2 and NF-ĸB activity. Additionally, NOD1 negatively regulated the phosphorylation status of cofilin, which inhibits actin turnover. Co-immunoprecipitation assays identified HCLS1-associated protein X-1 (HAX-1) as a previously unknown interaction partner of NOD1. Silencing of HAX-1 expression reduced the migration behaviour to similar levels as NOD1 knockdown, and simultaneous knockdown of NOD1 and HAX-1 showed no additive effect, suggesting that both proteins act in the same pathway. In conclusion, our data revealed an important role of the PRR NOD1 in regulating cell migration as well as chemotaxis in human cervical cancer cells and identified HAX-1 as a protein that interacts with NOD1 and is involved in this signalling pathway.en
dc.identifier10.1111/febs.16912en
dc.identifierFEBS16912en
dc.identifierFJ-23-0097.R1en
dc.identifier.urihttps://doi.org/10.1111/febs.16912
dc.identifier.urihttps://hohpublica.uni-hohenheim.de/handle/123456789/15903
dc.language.isoeng
dc.relation.ispartofThe FEBS Journalen
dc.rights.licensecc_by-nc-nd
dc.subjectCancer
dc.subjectChemotaxis
dc.subjectInnate immunity
dc.subjectNod-like receptors
dc.subjectRIPK2
dc.subject.ddc610
dc.titleNOD1 cooperates with HAX‐1 to promote cell migration in a RIPK2‐ and NF‐ĸB‐independent manneren
dc.type.diniArticle
dcterms.bibliographicCitationThe FEBS journal, 290 (2023), 22, 5295-5312. https://doi.org/10.1111/febs.16912. ISSN: 1742-4658
dcterms.bibliographicCitation.issn1742-4658
dcterms.bibliographicCitation.issue22
dcterms.bibliographicCitation.journaltitleThe FEBS journal
dcterms.bibliographicCitation.originalpublishernameWiley-Blackwell
dcterms.bibliographicCitation.originalpublisherplaceOxford [u.a.]
dcterms.bibliographicCitation.pageend5312
dcterms.bibliographicCitation.pagestart5295
dcterms.bibliographicCitation.volume290
local.export.bibtex@article{Hezinger2023, doi = {10.1111/febs.16912}, author = {Hezinger, Lucy and Bauer, Sarah and Ellwanger, Kornelia et al.}, title = {NOD1 cooperates with HAX‐1 to promote cell migration in a RIPK2‐ and NF‐ĸB‐independent manner}, journal = {The FEBS journal}, year = {2023}, volume = {290}, number = {22}, pages = {5295--5312}, }
local.export.bibtexAuthorHezinger, Lucy and Bauer, Sarah and Ellwanger, Kornelia et al.
local.export.bibtexKeyHezinger2023
local.export.bibtexPages5295--5312
local.export.bibtexType@article

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
FEBS_FEBS16912.pdf
Size:
2.62 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
supporting_information.zip
Size:
6.06 MB
Format:
Unknown data format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
7.85 KB
Format:
Item-specific license agreed to upon submission
Description: